Thereby, due to the increased ADCY4 expression in placentas from third trimester (HbSC group), we suggest that biological processes involved ADCY4 could be increased in this gestational age, impairing the placenta development in women with SC hemoglobinopathy. Here, ADCY4 is linked to hemoglobinopathy.